Akamai Technologies (AKAM) delivered mixed results in FY2026 on revenue of $125.1B versus the $125.6B estimate (+0.7% YoY) and EPS of $2.96. Below is the full Akamai Technologies earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
$125.1B (vs $125.6B est · -0.4% surprise · +0.7% YoY)
EPS
$2.96 (vs $2.79 est · +6.1% surprise · -3.5% YoY)
Share price
$108.81 (+3.7%)
Market cap
$970.0B
Top institutional holders
Holder
% outstanding
Shares
Value
QoQ change
Capital World Investors
7.7%
11.2M
$1.3B
+65.6%
Blackrock, INC.
7.2%
10.5M
$1.2B
+0.4%
Vanguard Capital Management LLC
6.5%
9.5M
$1.1B
+1.2%
Jane Street Group, LLC
5.9%
8.5M
$1.0B
+358.2%
Undisclosed filer
5.0%
7.3M
$857.9M
-3.6%
Wells Fargo & Company/Mn
4.0%
5.8M
$685.6M
+11500.0%
State Street Corp
4.0%
5.8M
$682.6M
+4.7%
First Trust Advisors LP
3.3%
4.8M
$561.7M
-0.6%
Geode Capital Management, LLC
2.9%
4.2M
$501.5M
+2.7%
Invesco Ltd.
2.7%
3.9M
$462.6M
+12.5%
Recent insider transactions
Insider
Role
Date
Type
Shares
Value
Joseph Paul C
officer: EVP - Global Sales
2026-07-15
Sell
3K
$392987
Blumofe Robert
officer: Chief Technology Officer
2026-06-18
Sell
243
$31447
Howell Laura
officer: SVP, Chief Accounting Officer
2026-06-12
Buy
322
—
Howell Laura
officer: SVP, Chief Accounting Officer
2026-06-12
Sell
95
$12584
Howell Laura
officer: SVP, Chief Accounting Officer
2026-06-12
Sell
322
—
Salem-Jackson Kim
officer: EVP, Chief Marketing Officer
2026-06-10
Sell
2K
$311811
HESSE DANIEL
director
2026-05-20
Buy
2K
—
HESSE DANIEL
director
2026-05-20
Sell
2K
—
What you'll find
Next Akamai Technologies (AKAM) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment Akamai Technologies reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in Akamai Technologies (AKAM)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is Akamai Technologies's next earnings date?
Magnisto tracks Akamai Technologies's (AKAM) earnings schedule and shows the confirmed next earnings date, the options-implied expected move and the estimates analysts are modeling into the print.
Did Akamai Technologies (AKAM) beat or miss earnings?
In FY2026, Akamai Technologies (AKAM) posted mixed results — revenue of $125.1B versus the $125.6B estimate (-0.4% surprise) and EPS of $2.96 versus $2.79 expected (+6.1% surprise). Magnisto decodes every Akamai Technologies (AKAM) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
Who are the largest shareholders of Akamai Technologies?
Institutions hold about 84.6% of Akamai Technologies's (AKAM) shares outstanding as of the 2026-06-30 13F quarter. Its largest institutional holders include Capital World Investors (7.7%), Blackrock, INC. (7.2%), Vanguard Capital Management LLC (6.5%). Magnisto lists Akamai Technologies's (AKAM) top 13F holders with each stake size and its quarter-over-quarter change.
Are insiders buying or selling Akamai Technologies (AKAM)?
In the most recent Form 4 filings Magnisto tracks, Akamai Technologies (AKAM) insiders recorded 5 purchases and 7 sales — net selling. Insider transactions are one signal among many and are often routine (option exercises or scheduled 10b5-1 sales), so Magnisto shows the raw feed for you to judge.
What is the forecast for Akamai Technologies (AKAM) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Akamai Technologies (AKAM), anchored to the current $108.81 share price, so you can weigh the bull, base and bear cases for Akamai Technologies side by side.
Is Akamai Technologies (AKAM) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Akamai Technologies fits your own thesis and risk profile. This is research, not investment advice.